Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Trends in Endocrinology and Metabolism: TEM
|
July 3, 2025
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology
Ruth Frampton, Samantha Hocking, Jennifer R Snaith, et al.
Trends in Endocrinology and Metabolism: TEM
|
December 12, 2019
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
BMJ Case Reports
|
May 2, 2020
Massive adrenal hyperplasia from paraneoplastic adrenocorticotropic hormone
Jennifer R Snaith, Bo Gao, David Chipps, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 20, 2020
Letter to the Editor: "Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry"
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Clinical Endocrinology
|
August 30, 2019
Nesidioblastosis following laparoscopic sleeve gastrectomy
Albert Kim, Jennifer R Snaith, Hema Mahajan, et al.
Diabetes Care
|
November 20, 2025
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
Jennifer R Snaith, Ruth Frampton, Dorit Samocha-Bonet, et al.
Lancet (London, England)
|
March 13, 2019
Excess mortality and cardiovascular disease risk in type 1 diabetes
Jennifer R Snaith, Deborah J Holmes-Walker, Christian M Girgis, et al.
Diabetes Care
|
August 29, 2025
Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches
Jennifer R Snaith, Phoom Narongkiatikhun, Petter Bjornstad, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 10, 2024
Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial
Ruth Frampton, Jennifer R Snaith, Samantha Hocking, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 28, 2021
Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial
Jennifer R Snaith, Dorit Samocha-Bonet, Jennifer Evans, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Trends in Endocrinology and Metabolism: TEM
|
July 3, 2025
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology
Ruth Frampton, Samantha Hocking, Jennifer R Snaith, et al.
Trends in Endocrinology and Metabolism: TEM
|
December 12, 2019
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
BMJ Case Reports
|
May 2, 2020
Massive adrenal hyperplasia from paraneoplastic adrenocorticotropic hormone
Jennifer R Snaith, Bo Gao, David Chipps, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 20, 2020
Letter to the Editor: "Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry"
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Clinical Endocrinology
|
August 30, 2019
Nesidioblastosis following laparoscopic sleeve gastrectomy
Albert Kim, Jennifer R Snaith, Hema Mahajan, et al.
Diabetes Care
|
November 20, 2025
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
Jennifer R Snaith, Ruth Frampton, Dorit Samocha-Bonet, et al.
Lancet (London, England)
|
March 13, 2019
Excess mortality and cardiovascular disease risk in type 1 diabetes
Jennifer R Snaith, Deborah J Holmes-Walker, Christian M Girgis, et al.
Diabetes Care
|
August 29, 2025
Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches
Jennifer R Snaith, Phoom Narongkiatikhun, Petter Bjornstad, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 10, 2024
Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial
Ruth Frampton, Jennifer R Snaith, Samantha Hocking, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 28, 2021
Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial
Jennifer R Snaith, Dorit Samocha-Bonet, Jennifer Evans, et al.
Page
of 3